8-KLeadership ChangesExhibits & Filings

Arthur J. Gallagher & Co. 8-K Report, Executive Changes (Jan 6, 2005)

Filed January 6, 2005For Securities:AJG

Summary

This Form 8-K filing by Arthur J. Gallagher & Co. (AJG) reports a significant change in its Board of Directors. Bernard L. Hengesbaugh, a current Director, has announced his intention not to stand for re-election at the May 2005 Annual Meeting of Shareholders. This decision stems from his recent appointment as Chief Operating Officer of the American Medical Association, a position that creates a conflict with his continued service on AJG's board. While Mr. Hengesbaugh will continue to serve until his term expires on May 17, 2005, his departure marks the end of his tenure as a director. Investors should note this change in board composition and consider the implications for corporate governance and strategic oversight. The company has also provided an attached press release as Exhibit 99 detailing this announcement.

Key Highlights

  • 1Bernard L. Hengesbaugh, a Director, will not seek re-election at the May 2005 Annual Meeting.
  • 2Mr. Hengesbaugh's decision is due to his new role as Chief Operating Officer of the American Medical Association.
  • 3He will continue to serve as a Director until his term expires on May 17, 2005.
  • 4This filing is classified under Item 5.02 (Departure of Directors or Principal Officers).
  • 5A press release dated January 6, 2005, announcing this change is attached as Exhibit 99 and incorporated by reference.
  • 6The company is incorporated in Delaware.

Frequently Asked Questions

Bernard L. Hengesbaugh is stepping down because he has accepted the position of Chief Operating Officer of the American Medical Association, which he believes conflicts with his ability to continue serving on the Arthur J. Gallagher & Co. Board of Directors.

Mr. Hengesbaugh will continue to serve as a Director until the expiration of his current term on May 17, 2005.

This filing indicates a change in the composition of the company's Board of Directors. Investors may want to consider the experience and background of the departing director and the potential impact on board dynamics and strategic decision-making.

More details can be found in the press release dated January 6, 2005, which is attached as Exhibit 99 to this Form 8-K filing and is incorporated by reference.